| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 02/11/2004 | CN1473573A 远红外多功能材料 Far-infrared multifunctional materials |
| 02/11/2004 | CN1137853C Electrolytic reduction water and its use, preparing method and device |
| 02/11/2004 | CN1137735C Medical oxygen-enriched liquid and oxygen-dissolving apparatus |
| 02/11/2004 | CN1137728C Anti-carious chewing gums, candies, gels, tooth-paste and dentifrices |
| 02/11/2004 | CN1137720C Chinese medicine for treating diabetes and its complication |
| 02/11/2004 | CN1137715C Chinese medicinal preparation for treating erythematosus |
| 02/11/2004 | CN1137711C Cream for treating burns, scalds and sore ulcer and its preparation |
| 02/11/2004 | CN1137710C Oral traditional Chinese medicine for treating calculus stone in urinary system |
| 02/11/2004 | CN1137705C Medicine for treating mental disease (psychosis) and its preparing method |
| 02/11/2004 | CN1137704C Chinese medicinal preparation for treating mental disease (psychosis) |
| 02/11/2004 | CN1137695C Plaster for curing hemiplegia and hypertension |
| 02/11/2004 | CN1137693C Ointment for treating burn |
| 02/10/2004 | US6689810 Contacting mammalian cells with nitric oxide mediator, wherein nitric oxide mediator is selected from pyruvates, pyruvate precursors, alpha -keto acids having four or more carbon atoms, precursors of alpha -keto acids for therapy |
| 02/10/2004 | US6689803 Administering anti-microtubule compound-containing, pharmaceutically acceptable formulation wherein anti-microtubule compound is paclitaxel for therapy and prophylaxis of surgical adhesions |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689404 Iodinated protein which includes at least phenylalanine or tryptophan; iodinated lactoglobulin |
| 02/10/2004 | US6689393 Glucose concentration can be varied without influencing the concentration of the other components; three individual solutions are combined and administered after heat sterilization; calcium ions, electrolyte salts, and a buffer |
| 02/10/2004 | US6689339 Freckles |
| 02/10/2004 | US6689275 Method and pharmaceutical composition for replacing iron losses in dialysis patients |
| 02/10/2004 | CA2101697C Controlled release potassium chloride tablet |
| 02/05/2004 | WO2004011011A1 Oral and dental composition |
| 02/05/2004 | WO2003092589A3 Salt solution for colon cleansing |
| 02/05/2004 | WO2003070167A3 Therapeutic and prophylactic treatment of aging and disorders of aging in humans |
| 02/05/2004 | WO2003066067A3 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| 02/05/2004 | US20040023937 Anti-cancer formulation |
| 02/05/2004 | US20040023934 Method of treating prostatic diseases using active vitamin D analogues |
| 02/05/2004 | US20040023931 Method for maintaining a healthy bone structure by administering to a patient a bone health promoting effective amount of a medicament containing 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic |
| 02/05/2004 | US20040022873 Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as anthrax, smallpox or radiation and for vaccination prophylaxis, and use in combination with DHEA for the treatment of smallpox and other viruses |
| 02/05/2004 | US20040022872 Antacid and laxative tablets |
| 02/05/2004 | US20040022871 Halogenated composition, method for preparing same and uses thereof |
| 02/05/2004 | US20040022868 Free of added persulfates. |
| 02/05/2004 | US20040022867 Neutralizes the adverse health effects of both chemical and biological compounds, especially chemical and biological warfare agents, and toxic industrial chemicals; includes solubilizers and oxididative detoxifiers |
| 02/05/2004 | US20040022866 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine |
| 02/05/2004 | US20040022863 Boric Acid, Zinc oxide, Calamine, Cetrimide, Olive Oil, Castor Oil, Cod liver Oil, White Petroleum base, Salicylic Acid, and Tannic Acid |
| 02/05/2004 | US20040022817 Non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered |
| 02/05/2004 | US20040022816 Fluid for haemofiltration |
| 02/05/2004 | US20040022745 Detergents useful in the healthcare and hard surface and fabric cleaning fields |
| 02/05/2004 | US20040022717 Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
| 02/05/2004 | US20040020864 Process for the debromination of an aqueous salt solution using ozone |
| 02/04/2004 | EP1386613A1 Compositions for preparing external carbon dioxide agents |
| 02/04/2004 | EP1385547A1 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 02/04/2004 | EP1385532A1 Stimulation of osteogenesis using rank ligand fusion proteins |
| 02/04/2004 | EP1385525A2 Targeted oxidative therapeutic formulation |
| 02/04/2004 | EP1385482A1 An effervescent solid composition of matter |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1339416A4 Trace elements |
| 02/04/2004 | EP1021196B1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 02/04/2004 | CN1473265A Method for producing purified hematinic iron-saccharidic complex and product produced |
| 02/04/2004 | CN1473055A Methods for enhancing efficacy of cytotoxic agents through use of HSP90 inhibitors |
| 02/04/2004 | CN1473049A Antiacid and laxative tablets |
| 02/04/2004 | CN1471981A Surface treatment for SARS lungs bacteria infection |
| 02/04/2004 | CN1471960A Preparation of xinxue granules |
| 02/04/2004 | CN1471957A Moschus safflower capsules for activating blood and generating bone |
| 02/04/2004 | CN1471941A Chinese medicine haemorrhoids ointment |
| 02/04/2004 | CN1471926A Injection for enhancing immunity and its preparing method |
| 02/04/2004 | CN1471925A Arsenic contained composition for directly hard tumour medoicine feed, preparation, preparing method thereof |
| 02/04/2004 | CN1471924A Medicinal liquid for resuming presbyopia eyesight |
| 02/04/2004 | CN1136909C Liniment 'Rubikang' and its preparing process |
| 02/04/2004 | CN1136885C Chinese medicine for treating dyspneic cough effectively |
| 02/04/2004 | CN1136875C Chuqin Zihou San and its preparing process |
| 02/04/2004 | CN1136869C Recovery capsule for hepatitis and its preparing process |
| 02/04/2004 | CN1136868C Medicine for preventing and treating hyperosteogeny and its preparing process |
| 02/04/2004 | CN1136865C Wound curing and swelling-eliminating traditional Chinese medicine ointment |
| 02/04/2004 | CN1136857C Traditional Chinese medicine external preparation for curing piles |
| 02/04/2004 | CN1136856C Use of strontium salts for production of pharmaceutical compositions intended for treatment of arthrosis |
| 02/03/2004 | US6686340 Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells |
| 02/03/2004 | US6686155 Treatment of tumor; obtain tissue sample, extract nucleotide sequences, amplify, detect preferential nucleotide sequences, incbate with antitumor agent, monitor sequence expression, adjustment in expression indicates effective antitumor agent |
| 02/03/2004 | US6685969 Treatment for ectoparasites |
| 02/03/2004 | US6685968 Protecting fresh cut lumber and logs from sap stain by applying a 1-10% aqueous boric acid solution to the wood surface |
| 02/03/2004 | US6685908 Reacting an aqueous calcium hydroxide slurry with carbon dioxide; high quality white pigment; low specific gravity |
| 01/29/2004 | WO2004009108A1 Antipyrotic and method of manufacturing the same |
| 01/29/2004 | WO2004009101A1 Gel composition comprising sea salts |
| 01/29/2004 | WO2004009084A1 Methods of treating infection using antibiotics and glycogen phosphorylase inhibitors |
| 01/29/2004 | WO2004009072A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/29/2004 | WO2004009064A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 01/29/2004 | WO2003088748A8 Use of heme oxygenase-1 and products of heme degradation |
| 01/29/2004 | US20040019130 Aqueous solution mixture of polymer, calcium compound and phosphate; buffered pH |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019102 Administering a thiuram disulfide and a heavy metal ion; activated transcription factor/adenosine cyclic phosphate response element binding protein (atf/creb) |
| 01/29/2004 | US20040018996 Unit dosage forms for the treatment of herpes simplex |
| 01/29/2004 | US20040018966 Methods and compositions for use in perfusion applications |
| 01/29/2004 | US20040018251 Petasite extract is recovered from plant of the genus Petasites; effective in treating gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure |
| 01/29/2004 | US20040018249 By mechanical treatment of aqueous suspensions of magaldrate powder |
| 01/29/2004 | US20040018248 Composition containing statins and calcium for improved cardiovascular health |
| 01/29/2004 | US20040018246 Invention relates to identification of HD-2, a natural chemical substance separated and purified from natural product, Sinsuk, as arsenic hexoxide |
| 01/29/2004 | US20040018245 Use of potassium for production of cardioplegic solution for prevention of stone heart development during acute cardiac ventricular fibrillation in connection with cardiopulmonary resuscitation |
| 01/29/2004 | US20040017021 Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver |
| 01/29/2004 | DE10233108A1 Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel Retarded painkillers containing Tilidin and a light stabilizer |
| 01/29/2004 | CA2493341A1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/28/2004 | EP1383563A2 Methods for the treatment of hiv and other viruses |
| 01/28/2004 | EP1383522A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 01/28/2004 | EP1383521A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/28/2004 | EP1383520A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/28/2004 | EP1383519A2 Treatment solution used for caring for wounds in addition to dressing material for use with said treatment solution |
| 01/28/2004 | EP1383494A2 Compositions and methods for the prevention and treatment of human prostate cancer |
| 01/28/2004 | EP1383490A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/28/2004 | EP1383399A1 Nutritional supplement to treat macular degeneration |
| 01/28/2004 | EP1383379A1 Restoration of cancer-suppressing functions to neoplastic cells through dna hypomethylation |
| 01/28/2004 | EP0959889B1 Use of neutral gallium chelates of 3-hydroxy-4-pyrone compounds for the treatment of diseases that can be ameliorated by inhibiting keratinocyte hyperproliferation |
| 01/28/2004 | CN1471408A Methods of treatment of a BCL-2 disorder using BCL-2 antisense oligomers |